Savara (SVRA) Return on Capital Employed Growth (3y) (2014 - 2026)
Savara (SVRA) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - | - |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn | 4,853.00 |
| 10 | Savara | 1.40 Bn | 1.40 Bn | - | -2,731.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,731.00 |
| Dec 31, 2025 | -4,172.00 |
| Sep 30, 2025 | -6,322.00 |
| Jun 30, 2025 | -4,796.00 |
| Mar 31, 2025 | -3,248.00 |
| Dec 31, 2024 | -2,408.00 |
| Sep 30, 2024 | -2,661.00 |
| Jun 30, 2024 | -3,633.00 |
| Mar 31, 2024 | -1,462.00 |
| Dec 31, 2023 | 1,623.00 |
| Sep 30, 2023 | 2,731.00 |
| Jun 30, 2023 | 2,398.00 |
| Mar 31, 2023 | 3,532.00 |
| Dec 31, 2022 | 3,380.00 |
| Sep 30, 2022 | 1,854.00 |
| Jun 30, 2022 | 1,993.00 |
| Mar 31, 2022 | 1,076.00 |
| Dec 31, 2021 | 2,303.00 |
| Sep 30, 2021 | 2,854.00 |
| Jun 30, 2021 | 2,891.00 |